Lakewood Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+175
New +$179K 0.12% 103
2026
Q1
Sell
-189
Closed -$203K 109
2025
Q4
$203K Buy
+189
New +$181K 0.12% 98
2025
Q1
Sell
-720
Closed -$556K 112
2024
Q4
$556K Sell
720
-10
-1% -$8.28K 0.38% 66
2024
Q3
$646K Buy
730
+1
+0.1% +$899 0.44% 64
2024
Q2
$660K Hold
729
0.46% 61
2024
Q1
$567K Sell
729
-110
-13% -$78.3K 0.39% 64
2023
Q4
$489K Hold
839
0.38% 63
2023
Q3
$450K Hold
839
0.37% 63
2023
Q2
$393K Buy
839
+1
+0.1% +$419 0.31% 75
2023
Q1
$288K Sell
838
-14
-2% -$4.72K 0.24% 85
2022
Q4
$312K Buy
+852
New +$302K 0.25% 79

Other funds holding LLY

Lakewood Asset Management's LLY Position: Q2 2026 in Review

Lakewood Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 175 shares worth $210K. The stake represents 0.12% of the portfolio and ranks #103 among its holdings. This is a return to the name: Lakewood Asset Management previously reported a position in LLY as recently as Q4 2025.

Lakewood Asset Management first reported a position in LLY in Q4 2022 and has held it in 11 quarters since. The position peaked at $660K in Q2 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lakewood Asset Management held 175 shares of Eli Lilly worth $210K as of Q2 2026.
  • Eli Lilly was a new Lakewood Asset Management position in Q2 2026.
  • Eli Lilly made up 0.12% of Lakewood Asset Management's portfolio in Q2 2026, its #103 holding.
  • Lakewood Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 11 quarters since.
  • Lakewood Asset Management's Eli Lilly position peaked at $660K in Q2 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lakewood Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.